2023 Q3 Form 10-Q Financial Statement

#000121390023069526 Filed on August 22, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $370.0K $300.0K $100.0K
YoY Change -29.34% 200.0% -78.2%
Operating Profit -$370.0K -$303.3K -$101.9K
YoY Change -29.35% 197.69% -77.78%
Interest Expense $166.5K $152.2K
YoY Change 20385.49%
% of Operating Profit
Other Income/Expense, Net -$679.7K -$1.202M $912.5K
YoY Change -134.21% -231.7% -181.01%
Pretax Income -$1.050M -$1.505M $810.6K
YoY Change -171.75% -285.68% -151.14%
Income Tax $26.94K $5.149K
% Of Pretax Income
Net Earnings -$1.077M -$1.510M $810.6K
YoY Change -173.78% -286.32% -151.14%
Net Earnings / Revenue
Basic Earnings Per Share -$0.25 -$0.35 $0.08
Diluted Earnings Per Share -$0.25 -$0.35 $0.08
COMMON SHARES
Basic Shares Outstanding 4.320M shares 4.320M 10.50M
Diluted Shares Outstanding 4.319M shares 4.320M shares 10.50M

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $200.0K $0.00 $0.00
YoY Change 249900.0% -100.0%
Cash & Equivalents $181.7K $3.184K $1.239K
Short-Term Investments
Other Short-Term Assets $100.0K $100.0K $200.0K
YoY Change -60.47% -50.0% -1.17%
Inventory
Prepaid Expenses $149.1K $149.0K $168.4K
Receivables
Other Receivables
Total Short-Term Assets $349.4K $170.8K $169.6K
YoY Change 38.08% 0.73% -54.09%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $12.70M $12.80M $49.40M
YoY Change -27.65% -74.09% -57.69%
Other Assets
YoY Change
Total Long-Term Assets $12.69M $12.84M $49.39M
YoY Change -27.72% -74.01% -57.7%
TOTAL ASSETS
Total Short-Term Assets $349.4K $170.8K $169.6K
Total Long-Term Assets $12.69M $12.84M $49.39M
Total Assets $13.04M $13.01M $49.56M
YoY Change -26.78% -73.75% -57.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $200.0K $100.0K $900.0K
YoY Change -77.54% -88.89% 256.03%
Accrued Expenses $100.0K $100.0K $100.0K
YoY Change 0.0% 0.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $900.0K
YoY Change -100.0% -100.0%
Long-Term Debt Due $6.807M $2.321M
YoY Change 193.25%
Total Short-Term Liabilities $7.548M $7.057M $4.165M
YoY Change 60.17% 69.43% 837.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.200M $2.400M $2.800M
YoY Change 278.14% -14.29% -77.84%
Total Long-Term Liabilities $3.200M $2.400M $2.800M
YoY Change 278.14% -14.29% -77.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.548M $7.057M $4.165M
Total Long-Term Liabilities $3.200M $2.400M $2.800M
Total Liabilities $10.76M $9.426M $6.927M
YoY Change 93.63% 36.08% -47.03%
SHAREHOLDERS EQUITY
Retained Earnings -$10.25M -$9.048M -$6.705M
YoY Change 93.25% 34.93% -47.44%
Common Stock $315.00 $315.00 $315.00
YoY Change 0.0% 0.0% 0.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$10.25M -$9.047M -$6.705M
YoY Change
Total Liabilities & Shareholders Equity $13.04M $13.01M $49.56M
YoY Change -26.78% -73.75% -57.68%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$1.077M -$1.510M $810.6K
YoY Change -173.78% -286.32% -151.14%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$290.0K -$460.0K -$720.0K
YoY Change -79.01% -36.11% 302.64%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $320.0K -$110.0K $69.81M
YoY Change -99.69% -100.16%
Cash From Investing Activities $320.0K -$110.0K $69.81M
YoY Change -99.69% -100.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 140.0K 540.0K -69.09M
YoY Change -100.14% -100.78%
NET CHANGE
Cash From Operating Activities -290.0K -460.0K -720.0K
Cash From Investing Activities 320.0K -110.0K 69.81M
Cash From Financing Activities 140.0K 540.0K -69.09M
Net Change In Cash 170.0K -30.00K 0.000
YoY Change -1876.38% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$290.0K -$460.0K -$720.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q2 brez Business Combination Right Convertible Share Of Common Stock Conversion Ratio
BusinessCombinationRightConvertibleShareOfCommonStockConversionRatio
0.05 pure
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001817640
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39718
dei Entity Registrant Name
EntityRegistrantName
BREEZE HOLDINGS ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1849315
dei Entity Address Address Line1
EntityAddressAddressLine1
955 W. John Carpenter Freeway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100-929
dei Entity Address City Or Town
EntityAddressCityOrTown
Irving
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75039
dei City Area Code
CityAreaCode
(619)
dei Local Phone Number
LocalPhoneNumber
500-7747
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4320484 shares
CY2023Q2 us-gaap Cash
Cash
3184 usd
CY2022Q4 us-gaap Cash
Cash
14129 usd
CY2023Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
18672 usd
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
18073 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
148993 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
160503 usd
CY2023Q2 brez Prepayment Franchise Taxes Current
PrepaymentFranchiseTaxesCurrent
usd
CY2022Q4 brez Prepayment Franchise Taxes Current
PrepaymentFranchiseTaxesCurrent
10000 usd
CY2023Q2 brez Prepaid Income Taxes Current
PrepaidIncomeTaxesCurrent
usd
CY2022Q4 brez Prepaid Income Taxes Current
PrepaidIncomeTaxesCurrent
usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
170849 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
202705 usd
CY2023Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
12839133 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
17730969 usd
CY2023Q2 us-gaap Assets
Assets
13009982 usd
CY2022Q4 us-gaap Assets
Assets
17933674 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
147472 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
67500 usd
CY2023Q2 brez Franchise Tax Payable
FranchiseTaxPayable
48400 usd
CY2022Q4 brez Franchise Tax Payable
FranchiseTaxPayable
usd
CY2023Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
53959 usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
usd
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2089 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
6806706 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5480941 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7056537 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5550530 usd
CY2023Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2369500 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1184750 usd
CY2023Q2 us-gaap Liabilities
Liabilities
9426037 usd
CY2022Q4 us-gaap Liabilities
Liabilities
6735280 usd
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1690196 shares
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
12631179 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
17730156 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3140000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3140000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3140000 shares
CY2023Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1180484 shares
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1690196 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
315 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
315 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9047549 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6532077 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-9047234 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6531762 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13009982 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17933674 usd
CY2023Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
303335 usd
CY2022Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
101896 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1193464 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1086990 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-303335 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-101896 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1193464 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1086990 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
220511 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
CY2022Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
66260 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
119144 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1354000 usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-846250 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1184750 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4346250 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
912510 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-964239 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4465394 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1505151 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
810614 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3378404 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5149 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6858 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1510300 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
810614 usd
us-gaap Net Income Loss
NetIncomeLoss
-2164561 usd
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4320484 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4320484 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10496623 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10496623 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4548587 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4548587 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12556866 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6531762 usd
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
173001 usd
CY2023Q1 brez Equity Adjustment Related To Excise Taxes Payable
EquityAdjustmentRelatedToExciseTaxesPayable
53959 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-654261 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-7412983 usd
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
123951 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1510300 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-9047234 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-8919146 usd
CY2022Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1150000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2567790 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-7501356 usd
CY2022Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
14213 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
810614 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-6704955 usd
us-gaap Profit Loss
ProfitLoss
-2164561 usd
us-gaap Profit Loss
ProfitLoss
3378404 usd
brez Interest And Unrealized Gain Loss On Investments
InterestAndUnrealizedGainLossOnInvestments
220511 usd
brez Interest And Unrealized Gain Loss On Investments
InterestAndUnrealizedGainLossOnInvestments
119144 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1184750 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4346250 usd
brez Increase Decrease In Prepaid Expenses And Other Liabilities
IncreaseDecreaseInPrepaidExpensesAndOtherLiabilities
-20910 usd
brez Increase Decrease In Prepaid Expenses And Other Liabilities
IncreaseDecreaseInPrepaidExpensesAndOtherLiabilities
44212 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
79972 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
259077 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2089 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
brez Increase Decrease In Franchise Taxes Payable
IncreaseDecreaseInFranchiseTaxesPayable
48400 usd
brez Increase Decrease In Franchise Taxes Payable
IncreaseDecreaseInFranchiseTaxesPayable
-100822 usd
brez Increase Decrease In Current Portion Of Long Term Liabilities
IncreaseDecreaseInCurrentPortionOfLongTermLiabilities
usd
brez Increase Decrease In Current Portion Of Long Term Liabilities
IncreaseDecreaseInCurrentPortionOfLongTermLiabilities
-27193 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1053129 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1000140 usd
us-gaap Payments To Acquire Trust Preferred Investments
PaymentsToAcquireTrustPreferredInvestments
283581 usd
us-gaap Payments To Acquire Trust Preferred Investments
PaymentsToAcquireTrustPreferredInvestments
1150000 usd
brez Cash Withdrawn From Trust Account To Redeeming Shareholders
CashWithdrawnFromTrustAccountToRedeemingShareholders
5395929 usd
brez Cash Withdrawn From Trust Account To Redeeming Shareholders
CashWithdrawnFromTrustAccountToRedeemingShareholders
69700629 usd
brez Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
usd
brez Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
109000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5112348 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
68659629 usd
brez Proceeds From Short Term Working Capital Loan Related Party
ProceedsFromShortTermWorkingCapitalLoanRelatedParty
1083500 usd
brez Proceeds From Short Term Working Capital Loan Related Party
ProceedsFromShortTermWorkingCapitalLoanRelatedParty
886975 usd
brez Proceeds From Promissory Note Related Party
ProceedsFromPromissoryNoteRelatedParty
242265 usd
brez Proceeds From Promissory Note Related Party
ProceedsFromPromissoryNoteRelatedParty
1150000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5395929 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
69700628 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4070164 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-67663653 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10945 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4164 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14129 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5403 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3184 usd
brez Non Cash Excise Taxes Payable
NonCashExciseTaxesPayable
usd
brez Accretion Of Common Stocks Subject To Redemption Value
AccretionOfCommonStocksSubjectToRedemptionValue
296952 usd
brez Accretion Of Common Stocks Subject To Redemption Value
AccretionOfCommonStocksSubjectToRedemptionValue
1164213 usd
CY2020Q4 brez Sale Of Private Placement Warrants
SaleOfPrivatePlacementWarrants
5425000 shares
CY2020Q4 brez Cost Of Per Private Placement Warrant
CostOfPerPrivatePlacementWarrant
1
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
4099907 usd
CY2020Q4 brez Underwriting Fees
UnderwritingFees
2300000 usd
CY2020Q4 brez Other Offering Costs
OtherOfferingCosts
477557 usd
CY2023Q2 us-gaap Cash
Cash
3184 usd
CY2023Q2 brez Aggregate Fair Market Value Of Acquisition Threshold As Percentage Of Assets Held In Trust Account
AggregateFairMarketValueOfAcquisitionThresholdAsPercentageOfAssetsHeldInTrustAccount
0.80 pure
brez Minimum Voting Interest To Be Owned Or Acquired To Complete Business Combination
MinimumVotingInterestToBeOwnedOrAcquiredToCompleteBusinessCombination
0.50 pure
CY2023Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.15
CY2023Q2 brez Business Combination Minimum Threshold Limit Of Net Intangible Assets Required
BusinessCombinationMinimumThresholdLimitOfNetIntangibleAssetsRequired
5000001 usd
brez Restriction On Public Share Redemption In Case Of Stockholder Approval Of Business Combination
RestrictionOnPublicShareRedemptionInCaseOfStockholderApprovalOfBusinessCombination
0.10 pure
brez Business Combination Incomplete Percentage Of Stock Redemption
BusinessCombinationIncompletePercentageOfStockRedemption
1 pure
CY2022Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.35
CY2022Q2 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
6732987 shares
CY2022Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
69700628 usd
CY2022Q2 brez Cash Withdrawn From Trust Account
CashWithdrawnFromTrustAccount
109000 usd
CY2022Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.35
CY2022Q3 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
3076817 shares
CY2022Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
31845056 usd
CY2022Q3 brez Cash Withdrawn From Trust Account
CashWithdrawnFromTrustAccount
122247 usd
CY2022Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.035
CY2022Q3 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
59157 usd
CY2022Q3 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
59157 usd
brez Business Combination Completion Date Of Acquisition
BusinessCombinationCompletionDateOfAcquisition
2023-09-26
CY2023Q2 brez Business Combination Incomplete Maximum Dissolution Expenses To Be Paid
BusinessCombinationIncompleteMaximumDissolutionExpensesToBePaid
100000 usd
brez Assets Remaining Available For Distribution Per Share Maximum
AssetsRemainingAvailableForDistributionPerShareMaximum
10.7
CY2022Q4 brez Business Combination Expected To Close
BusinessCombinationExpectedToClose
fourth quarter of 2023
CY2023Q2 us-gaap Cash
Cash
3184 usd
CY2023Q2 brez Working Capital
WorkingCapital
6837288 usd
CY2020Q4 brez Proceeds From Sale Of Founder Shares
ProceedsFromSaleOfFounderShares
25000 usd
CY2020Q4 brez Proceeds From Unsecured And Non Interest Bearing Promissory Notes
ProceedsFromUnsecuredAndNonInterestBearingPromissoryNotes
300000 usd
CY2023Q1 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
509712 shares
CY2023Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
5400000 usd
CY2023Q1 brez Percentage Of Excise Tax On Redemption Amount Paid
PercentageOfExciseTaxOnRedemptionAmountPaid
0.01 pure
CY2023Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
53959 usd
CY2023Q1 brez Percentage Of Excise Tax Liability Shares Redeemed
PercentageOfExciseTaxLiabilitySharesRedeemed
0.01 pure
us-gaap Use Of Estimates
UseOfEstimates
<p class="highlightCont" style="margin: 0px; text-indent: 0px; font-style: italic; font-size: 10pt; font-family: 'Times New Roman'; text-transform: none; font-variant: normal;"><span style="font-weight: bold; line-height: inherit; font-size: 10pt;">Use of estimates</span></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-style: italic; font-size: 10pt; font-family: 'Times New Roman'; text-transform: none; font-variant: normal;"><br/></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; font-style: normal; text-transform: none; font-variant: normal;"><span style="font-size: 10pt; line-height: inherit;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; font-style: normal; text-transform: none; font-variant: normal;"><br/></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; font-style: normal; text-transform: none; font-variant: normal;"><span style="font-size: 10pt; line-height: inherit;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p>
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q2 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
6732987 shares
CY2022Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
4767013 shares
CY2022Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.35
CY2022Q3 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
3076817 shares
CY2022Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1690196 shares
CY2023Q1 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.56
CY2023Q1 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
509712 shares
CY2023Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1180484 shares
brez Offering Costs Incurred In Connection With Issuance Of Common Stock
OfferingCostsIncurredInConnectionWithIssuanceOfCommonStock
3704282 usd
CY2023Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1180484 shares
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1690196 shares
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1510300 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
810614 usd
us-gaap Net Income Loss
NetIncomeLoss
3378404 usd
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4320484 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4320484 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10496623 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4548587 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4548587 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12556866 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12556866 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-style: italic; font-size: 10pt; font-family: 'Times New Roman'; text-transform: none; font-variant: normal; line-height: 1.2;"><span style="font-weight: bold; line-height: inherit; font-size: 10pt;">Concentration of credit risk</span></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-style: italic; font-size: 10pt; font-family: 'Times New Roman'; text-transform: none; font-variant: normal; line-height: 1.2;"><br/></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; font-style: normal; text-transform: none; font-variant: normal; line-height: 1.2;"><span style="font-size: 10pt; line-height: inherit;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the FDIC coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p>
us-gaap Concentration Risk Credit Risk Financial Instrument Maximum Exposure
ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
250000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7108500 usd
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
3500000 usd
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3608500 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
846250 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2762250 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1184750 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
169250 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1015500 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-1354000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2369500 usd
brez Percentage Of Advisor Cash Fee On Gross Proceeds Of Initial Public Offering
PercentageOfAdvisorCashFeeOnGrossProceedsOfInitialPublicOffering
0.0275 pure
brez Cash Fee For Advisory Services Upon Consummation Of Business Combination
CashFeeForAdvisoryServicesUponConsummationOfBusinessCombination
3162500 usd
CY2023Q2 brez Number Of Fractional Shares Issued Upon Exercise Of Public Warrant
NumberOfFractionalSharesIssuedUponExerciseOfPublicWarrant
0 shares
brez Warrants Exercisable Period After Completion Of Business Combination
WarrantsExercisablePeriodAfterCompletionOfBusinessCombination
P30D
brez Warrants Exercisable Period From Closing Of Initial Public Offering
WarrantsExercisablePeriodFromClosingOfInitialPublicOffering
P12M
brez Warrant Expiration Period After Completion Of Business Combination Or Earlier Upon Redemption Or Liquidation
WarrantExpirationPeriodAfterCompletionOfBusinessCombinationOrEarlierUponRedemptionOrLiquidation
P5Y
CY2023Q2 brez Class Of Warrant Or Right Redemption Price
ClassOfWarrantOrRightRedemptionPrice
0.01
brez Minimum Period Of Prior Written Notice Of Redemption Of Warrants
MinimumPeriodOfPriorWrittenNoticeOfRedemptionOfWarrants
P30D
CY2023Q2 brez Minimum Price Per Share Required For Redemption Of Warrants
MinimumPricePerShareRequiredForRedemptionOfWarrants
18
brez Warrants Redemption Covenant Threshold Trading Days
WarrantsRedemptionCovenantThresholdTradingDays
P20D
brez Warrants Redemption Covenant Threshold Consecutive Trading Days
WarrantsRedemptionCovenantThresholdConsecutiveTradingDays
P30D
CY2023Q2 brez Maximum Effective Issue Price To Closing Of Business Combination
MaximumEffectiveIssuePriceToClosingOfBusinessCombination
9.2
CY2023Q2 brez Minimum Percentage Of Equity Proceeds From Issuances
MinimumPercentageOfEquityProceedsFromIssuances
0.60 pure
brez Number Of Trading Days Prior On Consummates Business Combination
NumberOfTradingDaysPriorOnConsummatesBusinessCombination
P20D
CY2023Q2 brez Maximum Effective Issue Price To Closing Of Business Combination
MaximumEffectiveIssuePriceToClosingOfBusinessCombination
9.2
CY2023Q2 brez Percentage Of Exercise Price Of Warrants Adjusted Equal To Higher Of Market Value And Issued Price
PercentageOfExercisePriceOfWarrantsAdjustedEqualToHigherOfMarketValueAndIssuedPrice
1.15 pure
CY2023Q2 brez Minimum Price Per Share Required For Redemption Of Warrants
MinimumPricePerShareRequiredForRedemptionOfWarrants
18
brez Percentage Of Redemption Triggered Price Of Warrants Adjusted Equal To Higher Of Market Value And Issued Price
PercentageOfRedemptionTriggeredPriceOfWarrantsAdjustedEqualToHigherOfMarketValueAndIssuedPrice
1.80 pure
brez Warrants Will Not Be Transferable Assignable Or Saleable Number Of Period After Completion Of Business Combination
WarrantsWillNotBeTransferableAssignableOrSaleableNumberOfPeriodAfterCompletionOfBusinessCombination
P30D
CY2023Q2 brez Warrant Price Per Share
WarrantPricePerShare
1
CY2023Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
5425000 usd
CY2023Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
brez Warrants Will Not Be Transferable Assignable Or Saleable Number Of Period After Completion Of Business Combination
WarrantsWillNotBeTransferableAssignableOrSaleableNumberOfPeriodAfterCompletionOfBusinessCombination
P30D
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1184750 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4346250 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Holders of common stock are entitled to one vote for each share.
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3140000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3140000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3140000 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0032 pure
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0032 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure

Files In Submission

Name View Source Status
0001213900-23-069526-index-headers.html Edgar Link pending
0001213900-23-069526-index.html Edgar Link pending
0001213900-23-069526.txt Edgar Link pending
0001213900-23-069526-xbrl.zip Edgar Link pending
brez-20230630.htm Edgar Link pending
brez-20230630.xsd Edgar Link pending
brez-20230630_cal.xml Edgar Link unprocessable
brez-20230630_def.xml Edgar Link unprocessable
ex311_1.htm Edgar Link pending
ex321_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
brez-20230630_pre.xml Edgar Link unprocessable
brez-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
brez-20230630_htm.xml Edgar Link completed